Smith & Nephew SNATS - 19 Year Stock Price History | SNN
Historical daily stock prices for Smith & Nephew SNATS since 1999 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Smith & Nephew SNATS (SNN) as of July 20, 2018 is 35.47.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $4.765B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $118.977B | 18.41 |
| Abbott Laboratories (ABT) | United States | $111.012B | 23.28 |
| Stryker (SYK) | United States | $65.138B | 26.05 |
| Boston Scientific (BSX) | United States | $46.596B | 25.98 |
| Baxter (BAX) | United States | $40.161B | 28.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.697B | 14.30 |
| ResMed (RMD) | United States | $15.606B | 32.64 |
| Perrigo (PRGO) | Ireland | $10.519B | 14.75 |
| Bio-Rad Laboratories (BIO) | United States | $9.103B | 73.42 |
| Hill-Rom Holdings (HRC) | United States | $6.270B | 22.52 |
| ICU Medical (ICUI) | United States | $6.108B | 56.83 |
| Canopy Growth (CGC) | Canada | $5.270B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $5.246B | 0.00 |
| Haemonetics (HAE) | United States | $5.150B | 53.04 |
| Insulet (PODD) | United States | $5.146B | 0.00 |
| Hutchison China MediTech (HCM) | China | $4.495B | 0.00 |
| Neogen (NEOG) | United States | $4.235B | 67.72 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.061B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.046B | 0.00 |
| NuVasive (NUVA) | United States | $2.748B | 27.78 |
| Quidel (QDEL) | United States | $2.607B | 114.08 |
| Phibro Animal Health (PAHC) | United States | $1.915B | 28.44 |
| Abaxis,Inc (ABAX) | United States | $1.905B | 64.08 |
| NxStage Medical (NXTM) | United States | $1.838B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.450B | 22.34 |
| Eagle Pharmaceuticals (EGRX) | United States | $1.237B | 34.60 |
| Cardiovascular Systems (CSII) | United States | $1.178B | 0.00 |
| Orthofix (OFIX) | $1.126B | 34.30 | |
| Owens & Minor (OMI) | United States | $1.078B | 10.84 |
| AtriCure (ATRC) | United States | $1.041B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.034B | 62.70 |
| Cerus (CERS) | United States | $0.982B | 0.00 |
| Omeros (OMER) | United States | $0.948B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.948B | 0.00 |
| MacroGenics (MGNX) | United States | $0.940B | 0.00 |
| Surmodics (SRDX) | United States | $0.805B | 138.07 |
| LeMaitre Vascular (LMAT) | United States | $0.709B | 41.70 |
| Meridian Bioscience (VIVO) | United States | $0.671B | 23.66 |
| PetIQ (PETQ) | United States | $0.656B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.578B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.524B | 13.70 |
| Evolus (EOLS) | United States | $0.480B | 0.00 |
| Surface Oncology (SURF) | United States | $0.363B | 0.00 |
| Quanterix (QTRX) | United States | $0.358B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.356B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.355B | 23.52 |
| NanoString Technologies (NSTG) | United States | $0.314B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.311B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.242B | 0.00 |
| Chimerix (CMRX) | United States | $0.220B | 0.00 |
| Bovie Medical (BVX) | United States | $0.172B | 0.00 |
| Fonar (FONR) | United States | $0.172B | 10.42 |
| Chembio Diagnostics (CEMI) | United States | $0.160B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.133B | 0.00 |
| Female Health (VERU) | United States | $0.110B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.104B | 31.13 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.098B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 20.43 |
| Neurotrope (NTRP) | United States | $0.079B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.073B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.056B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.038B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.035B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.035B | 0.00 |
| Myomo (MYO) | United States | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.027B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.003B | 0.00 |
